AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Solvysita M 500 Tablet

Prescription Icon
Prescription Required

Marketer

Solvy Remedies Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Solvysita M 500 Tablet

Diabex Duo 500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like vision loss and kidney disease, potentially lowering heart attack and stroke risk. Diabex Duo 500mg may be used alone or with other antidiabetic drugs, and its effectiveness is enhanced by a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering health status, blood sugar readings, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for optimal diabetes control, as lifestyle significantly impacts management. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, and throat irritation. Low blood sugar (hypoglycemia) is a potential risk, especially when combined with insulin or sulfonylureas; patients should learn hypoglycemia recognition and management. This medication isn't suitable for everyone. Prior to use, disclose any history of kidney, liver, heart, or pancreatic disease, or significant alcohol consumption to your physician. Pregnant or breastfeeding individuals should consult their doctor before use. Inform your doctor about all other medications to ensure safety, as interactions may occur. Alcohol should be minimized due to its hypoglycemic effects. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Uses of Solvysita M 500 Tablet

Managing type 2 diabetes

Major Benefits of Solvysita M 500 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Solvysita M 500 Tablet with a meal.

Common Side effects of Solvysita M 500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Solvysita M 500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Solvysita M 500 Tablets. Ingest the tablets whole; do not chew, crush, or divide them. Administer this medication with a meal.

How Solvysita M 500 Tablet works:

Solvysita M 500 Tablet combines sitagliptin and metformin to manage blood sugar. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to more effective glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Solvysita M 500 Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Solvysita M 500 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Solvysita M 500 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Solvysita M 500 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of Solvysita M 500 Tablets is contraindicated in individuals with hepatic impairment and should be strictly avoided. Medical advice is recommended.

What if you forget to take Solvysita M 500 Tablet :

Should you forget a Solvysita M 500 Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Solvysita M 500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Solvysita M 500 Tablet

Solvysita M 500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Solvysita M 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, supplemental vitamin B12 is recommended annually by some researchers.
Solvysita M 500 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Solvysita M 500 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Solvysita M 500 Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Solvysita M 500 Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is a reason to avoid metformin in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Solvysita M 500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Solvysita M 500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Solvysita M 500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Solvysita M 500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Solvysita M 500 Tablet can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Solvysita M 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Solvysita M 500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. It improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Solvysita M 500 Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Solvysita M 500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Solvysita M 500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Solvysita M 500 Tablet can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid. Also known as MALA (Metformin-associated lactic acidosis), this rare side effect is a reason to avoid metformin in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Solvysita M 500 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left unaddressed, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Solvysita M 500 Tablet
172
MRP 200
13% off